Thermo Fisher Scientific

Thermo Fisher Scientific is engaged in serving science. The company's segments include: Life Sciences Solutions, which provides reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines as well as diagnosis of disease; Analytical Instruments, which provides instruments, consumables, software and services that are used for a range of applications in the laboratory, on the production line and in the field; and Specialty Diagnostics, which provides diagnostic test kits, reagents, culture media, instruments and associated products for customers in healthcare, clinical, pharmaceutical, industrial, and food safety laboratories.
  • TickerTMO
  • ISINUS8835561023
  • ExchangeNew York Stock Exchange
  • SectorHealth Care Equipment & Services
  • CountryUnited States
TMO Thermo Fisher S... (Health Care)

Thermo Fisher Scientific Inc. - December 2020 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Valens Research
  • Valens Research
TMO Thermo Fisher S... (Health Care)

TMO - Embedded Expectations Analysis - 2021 03 17

Thermo Fisher Scientific Inc. (TMO:USA) currently trades near historical highs relative to UAFRS-based (Uniform) earnings, with a 19.5x Uniform P/E. Even at these levels, the market has bearish expectations for the firm, and management may have concerns about the sustainability of demand, their ability to sustain margin expansion, and the potential of their investments Specifically, management may lack confidence in their ability to sustain adjusted operating margin expansion, further increase their installed base size, and capitalize on long-term growth opportunities. Furthermore, they may b...

TMO Thermo Fisher S... (Health Care)

An unfavourable environment weighs on THERMO FISHER SCIENTIFIC, which ...

The independent financial analyst theScreener just requalified the general evaluation of THERMO FISHER SCIENTIFIC (US), active in the Medical Equipment industry. As regards its fundamental valuation, the title still shows 1 out of 4 stars and its market behaviour is seen as defensive. theScreener believes that the unfavourable environment weighs on the sector and penalises the company, which sees a downgrade to its general evaluation to Neutral. As of the analysis date March 5, 2021, the closing price was USD 446.87 and its target price was estimated at USD 406.64.

TMO Thermo Fisher S... (Health Care)

Thermo Fisher Scientific Inc: 1 director sold

A director at Thermo Fisher Scientific Inc sold 7,290 shares at 507.790USD and the significance rating of the trade was 77/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The ...

TMO Thermo Fisher S... (Health Care)

Thermo Fisher Scientific Inc. - September 2020 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

TMO Thermo Fisher S... (Health Care)

Thermo Fisher Scientific Inc. - December 2020 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Valens Research
  • Valens Research
TMO Thermo Fisher S... (Health Care)

TMO - Embedded Expectations Analysis - 2021 03 17

Thermo Fisher Scientific Inc. (TMO:USA) currently trades near historical highs relative to UAFRS-based (Uniform) earnings, with a 19.5x Uniform P/E. Even at these levels, the market has bearish expectations for the firm, and management may have concerns about the sustainability of demand, their ability to sustain margin expansion, and the potential of their investments Specifically, management may lack confidence in their ability to sustain adjusted operating margin expansion, further increase their installed base size, and capitalize on long-term growth opportunities. Furthermore, they may b...

TMO Thermo Fisher S... (Health Care)

An unfavourable environment weighs on THERMO FISHER SCIENTIFIC, which ...

The independent financial analyst theScreener just requalified the general evaluation of THERMO FISHER SCIENTIFIC (US), active in the Medical Equipment industry. As regards its fundamental valuation, the title still shows 1 out of 4 stars and its market behaviour is seen as defensive. theScreener believes that the unfavourable environment weighs on the sector and penalises the company, which sees a downgrade to its general evaluation to Neutral. As of the analysis date March 5, 2021, the closing price was USD 446.87 and its target price was estimated at USD 406.64.

TMO Thermo Fisher S... (Health Care)

Thermo Fisher Scientific Inc: 1 director sold

A director at Thermo Fisher Scientific Inc sold 7,290 shares at 507.790USD and the significance rating of the trade was 77/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The ...

TMO Thermo Fisher S... (Health Care)

Thermo Fisher Scientific Inc. - September 2020 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

TMO Thermo Fisher S... (Health Care)

Thermo Fisher Scientific Inc. - December 2020 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Valens Research
  • Valens Research
TMO Thermo Fisher S... (Health Care)

TMO - Embedded Expectations Analysis - 2021 03 17

Thermo Fisher Scientific Inc. (TMO:USA) currently trades near historical highs relative to UAFRS-based (Uniform) earnings, with a 19.5x Uniform P/E. Even at these levels, the market has bearish expectations for the firm, and management may have concerns about the sustainability of demand, their ability to sustain margin expansion, and the potential of their investments Specifically, management may lack confidence in their ability to sustain adjusted operating margin expansion, further increase their installed base size, and capitalize on long-term growth opportunities. Furthermore, they may b...

TMO Thermo Fisher S... (Health Care)

An unfavourable environment weighs on THERMO FISHER SCIENTIFIC, which ...

The independent financial analyst theScreener just requalified the general evaluation of THERMO FISHER SCIENTIFIC (US), active in the Medical Equipment industry. As regards its fundamental valuation, the title still shows 1 out of 4 stars and its market behaviour is seen as defensive. theScreener believes that the unfavourable environment weighs on the sector and penalises the company, which sees a downgrade to its general evaluation to Neutral. As of the analysis date March 5, 2021, the closing price was USD 446.87 and its target price was estimated at USD 406.64.

TMO Thermo Fisher S... (Health Care)

Thermo Fisher Scientific Inc: 1 director sold

A director at Thermo Fisher Scientific Inc sold 7,290 shares at 507.790USD and the significance rating of the trade was 77/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The ...

TMO Thermo Fisher S... (Health Care)

Thermo Fisher Scientific Inc. - September 2020 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

TMO Thermo Fisher S... (Health Care)

Thermo Fisher Scientific Inc. - December 2020 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Valens Research
  • Valens Research
TMO Thermo Fisher S... (Health Care)

TMO - Embedded Expectations Analysis - 2021 03 17

Thermo Fisher Scientific Inc. (TMO:USA) currently trades near historical highs relative to UAFRS-based (Uniform) earnings, with a 19.5x Uniform P/E. Even at these levels, the market has bearish expectations for the firm, and management may have concerns about the sustainability of demand, their ability to sustain margin expansion, and the potential of their investments Specifically, management may lack confidence in their ability to sustain adjusted operating margin expansion, further increase their installed base size, and capitalize on long-term growth opportunities. Furthermore, they may b...

TMO Thermo Fisher S... (Health Care)

An unfavourable environment weighs on THERMO FISHER SCIENTIFIC, which ...

The independent financial analyst theScreener just requalified the general evaluation of THERMO FISHER SCIENTIFIC (US), active in the Medical Equipment industry. As regards its fundamental valuation, the title still shows 1 out of 4 stars and its market behaviour is seen as defensive. theScreener believes that the unfavourable environment weighs on the sector and penalises the company, which sees a downgrade to its general evaluation to Neutral. As of the analysis date March 5, 2021, the closing price was USD 446.87 and its target price was estimated at USD 406.64.

TMO Thermo Fisher S... (Health Care)

Thermo Fisher Scientific Inc: 1 director sold

A director at Thermo Fisher Scientific Inc sold 7,290 shares at 507.790USD and the significance rating of the trade was 77/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The ...

TMO Thermo Fisher S... (Health Care)

Thermo Fisher Scientific Inc. - September 2020 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

TMO Thermo Fisher S... (Health Care)

Thermo Fisher Scientific Inc. - December 2020 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Valens Research
  • Valens Research
TMO Thermo Fisher S... (Health Care)

TMO - Embedded Expectations Analysis - 2021 03 17

Thermo Fisher Scientific Inc. (TMO:USA) currently trades near historical highs relative to UAFRS-based (Uniform) earnings, with a 19.5x Uniform P/E. Even at these levels, the market has bearish expectations for the firm, and management may have concerns about the sustainability of demand, their ability to sustain margin expansion, and the potential of their investments Specifically, management may lack confidence in their ability to sustain adjusted operating margin expansion, further increase their installed base size, and capitalize on long-term growth opportunities. Furthermore, they may b...

TMO Thermo Fisher S... (Health Care)

An unfavourable environment weighs on THERMO FISHER SCIENTIFIC, which ...

The independent financial analyst theScreener just requalified the general evaluation of THERMO FISHER SCIENTIFIC (US), active in the Medical Equipment industry. As regards its fundamental valuation, the title still shows 1 out of 4 stars and its market behaviour is seen as defensive. theScreener believes that the unfavourable environment weighs on the sector and penalises the company, which sees a downgrade to its general evaluation to Neutral. As of the analysis date March 5, 2021, the closing price was USD 446.87 and its target price was estimated at USD 406.64.

TMO Thermo Fisher S... (Health Care)

Thermo Fisher Scientific Inc: 1 director sold

A director at Thermo Fisher Scientific Inc sold 7,290 shares at 507.790USD and the significance rating of the trade was 77/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The ...

TMO Thermo Fisher S... (Health Care)

Thermo Fisher Scientific Inc. - September 2020 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

TMO Thermo Fisher S... (Health Care)

Thermo Fisher Scientific Inc. - December 2020 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Valens Research
  • Valens Research
TMO Thermo Fisher S... (Health Care)

TMO - Embedded Expectations Analysis - 2021 03 17

Thermo Fisher Scientific Inc. (TMO:USA) currently trades near historical highs relative to UAFRS-based (Uniform) earnings, with a 19.5x Uniform P/E. Even at these levels, the market has bearish expectations for the firm, and management may have concerns about the sustainability of demand, their ability to sustain margin expansion, and the potential of their investments Specifically, management may lack confidence in their ability to sustain adjusted operating margin expansion, further increase their installed base size, and capitalize on long-term growth opportunities. Furthermore, they may b...

TMO Thermo Fisher S... (Health Care)

An unfavourable environment weighs on THERMO FISHER SCIENTIFIC, which ...

The independent financial analyst theScreener just requalified the general evaluation of THERMO FISHER SCIENTIFIC (US), active in the Medical Equipment industry. As regards its fundamental valuation, the title still shows 1 out of 4 stars and its market behaviour is seen as defensive. theScreener believes that the unfavourable environment weighs on the sector and penalises the company, which sees a downgrade to its general evaluation to Neutral. As of the analysis date March 5, 2021, the closing price was USD 446.87 and its target price was estimated at USD 406.64.

TMO Thermo Fisher S... (Health Care)

Thermo Fisher Scientific Inc: 1 director sold

A director at Thermo Fisher Scientific Inc sold 7,290 shares at 507.790USD and the significance rating of the trade was 77/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The ...

TMO Thermo Fisher S... (Health Care)

Thermo Fisher Scientific Inc. - September 2020 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch